Home > Boards > US Listed > Biotechs > Regeneron Pharmaceuticals (REGN)

News: $REGN First Clinical Data for REGN5458 (BCMAxCD3)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 58
Posts 7,611
Boards Moderated 0
Alias Born 06/04/18
160x600 placeholder
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Sever... PR Newswire (US) - 3/30/2020 11:46:00 AM
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 PR Newswire (US) - 3/30/2020 12:59:00 AM
Regeneron Announces Important Advances in Novel COVID-19 Antibody Program PR Newswire (US) - 3/17/2020 7:00:00 AM
Regeneron and Sanofi Start U.S. Studies Assessing Arthritis Drug As Coronavirus Treatment Dow Jones News - 3/16/2020 11:10:00 AM
Regeneron, Sanofi Start Trials for Drug to Treat Covid-19 Dow Jones News - 3/16/2020 8:57:00 AM
Regeneron and Sanofi Begin Global Kevzara® (sarilumab) Clinical Trial Program in Patients with Severe COVID-19 PR Newswire (US) - 3/16/2020 8:09:00 AM
Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19 PR Newswire (US) - 3/16/2020 8:00:00 AM
It's a Tough Time to Be in the C-Suite, Good Time to Be in a Gas Field Dow Jones News - 3/13/2020 7:29:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 5:00:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2020 4:06:26 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- 3rd Update Dow Jones News - 3/10/2020 7:27:00 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- 2nd Update Dow Jones News - 3/10/2020 6:24:00 PM
Biotech Stocks Stumble Despite Broad Market Rally Dow Jones News - 3/10/2020 6:21:00 PM
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment -- Update Dow Jones News - 3/10/2020 6:00:00 PM
Only 29 Stocks in the S&P 500 Show Gains for the Past Month--Update Dow Jones News - 3/10/2020 5:26:00 PM
Only 19 Stocks in the S&P 500 Are in the Green for the Past Month Dow Jones News - 3/10/2020 4:15:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2020 4:06:43 PM
Regeneron Up Over 4%, on Pace for Highest Close Since September 2017 -- Data Talk Dow Jones News - 3/4/2020 12:29:00 PM
Regeneron Announces Upcoming Investor Conference Presentations PR Newswire (US) - 3/3/2020 4:05:00 PM
Correction to Health-Care Stocks Article Dow Jones News - 3/1/2020 4:28:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/28/2020 4:47:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/28/2020 4:46:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/28/2020 4:34:46 PM
Amid Steep Declines in Stocks, Investors Seek Winners in Health Care Dow Jones News - 2/28/2020 3:59:00 PM
whytestocks   Sunday, 12/08/19 09:31:22 AM
Re: None
Post # of 141 
News: $REGN First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma

TARRYTOWN, N.Y. , Dec. 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.  (NASDAQ: REGN ) today announced initial clinical data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma. BCMA (B-cell maturation antigen) is...

Read the whole news REGN - First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist